BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6211491)

  • 41. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H.
    Blom AM; Kask L; Ramesh B; Hillarp A
    Arch Biochem Biophys; 2003 Oct; 418(2):108-18. PubMed ID: 14522582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
    Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification of the human complement control protein C3b inactivator.
    Crossley LG; Porter RR
    Biochem J; 1980 Oct; 191(1):173-82. PubMed ID: 6451220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells.
    Scheiner O; Schulz TF; Schmid HU; Lambris JD; Alsenz J; Dierich MP
    Immunobiology; 1983 Aug; 165(2):211-24. PubMed ID: 6226591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.
    Jouvin MH; Kazatchkine MD; Cahour A; Bernard N
    J Immunol; 1984 Dec; 133(6):3250-4. PubMed ID: 6238095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.
    Newman SL; Johnston RB
    J Immunol; 1979 Oct; 123(4):1839-46. PubMed ID: 573303
    [No Abstract]   [Full Text] [Related]  

  • 48. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
    Hannan JP; Laskowski J; Thurman JM; Hageman GS; Holers VM
    PLoS One; 2016; 11(11):e0166200. PubMed ID: 27814381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pattern of degradation of human complement fragment, C3b.
    Sim E; Wood AB; Hsiung LM; Sim RB
    FEBS Lett; 1981 Sep; 132(1):55-60. PubMed ID: 6457754
    [No Abstract]   [Full Text] [Related]  

  • 52. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 54. Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.
    Seya T; Nagasawa S
    J Biochem; 1985 Jan; 97(1):373-82. PubMed ID: 3158646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
    Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
    J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E; Eskeland T; Bertheussen K
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and structural studies on the complement-system control protein beta 1H (Factor H).
    Sim RB; DiScipio RG
    Biochem J; 1982 Aug; 205(2):285-93. PubMed ID: 6215918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.